EntryPoint Capital’s Clorox CLX Stock Holding History

EntryPoint Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-254	Closed	-$38.9K	–	993
2024 Q1	$38.9K	Buy	+254	New	+$37.9K	0.03%	870

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EntryPoint Capital's CLX Position: Q2 2024 in Review

EntryPoint Capital sold out of Clorox (CLX) in Q2 2024, closing a stake of 254 shares — an estimated $38.9K sold.

EntryPoint Capital first reported a position in CLX in Q1 2024 and held it in 1 quarter. The position peaked at $38.9K in Q1 2024. 1,091 funds tracked by Wall St. Rank hold CLX as of Q2 2024.

EntryPoint Capital reported no remaining Clorox position as of Q2 2024 after selling out during the quarter.
EntryPoint Capital sold 254 Clorox shares in Q2 2024, an estimated $38.9K.
EntryPoint Capital first reported a position in Clorox in Q1 2024 and held it in 1 quarter.
EntryPoint Capital's Clorox position peaked at $38.9K in Q1 2024.
1,091 funds tracked by Wall St. Rank held Clorox as of Q2 2024.

Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.